Bank of New York Mellon Corp Raises Holdings in Agilent Technologies, Inc. $A

Bank of New York Mellon Corp boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 42.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 2,857,820 shares of the medical research company’s stock after acquiring an additional 845,688 shares during the period. Bank of New York Mellon Corp’s holdings in Agilent Technologies were worth $388,864,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Massachusetts Financial Services Co. MA increased its holdings in Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after purchasing an additional 1,713,216 shares during the period. Wellington Management Group LLP increased its holdings in Agilent Technologies by 4.8% during the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after purchasing an additional 433,342 shares during the period. Geode Capital Management LLC increased its holdings in Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after purchasing an additional 25,139 shares during the period. Generation Investment Management LLP increased its holdings in Agilent Technologies by 10.1% during the 3rd quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after purchasing an additional 582,093 shares during the period. Finally, Norges Bank purchased a new stake in Agilent Technologies during the 4th quarter worth about $549,158,000.

Agilent Technologies Trading Up 0.6%

Shares of A stock opened at $138.23 on Friday. The business’s 50 day moving average is $117.89 and its two-hundred day moving average is $128.30. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.27. The company has a market capitalization of $39.04 billion, a P/E ratio of 27.76, a price-to-earnings-growth ratio of 2.45 and a beta of 1.26. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.84 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same period last year, the business posted $1.31 EPS. The company’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts forecast that Agilent Technologies, Inc. will post 5.99 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

Analyst Ratings Changes

A number of research analysts have recently commented on A shares. Barclays increased their price objective on Agilent Technologies from $140.00 to $145.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. UBS Group dropped their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a report on Tuesday. HSBC dropped their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Wells Fargo & Company dropped their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $161.71.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.